413 related articles for article (PubMed ID: 6239742)
21. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
Edelman J; Davis P; Owen ET
J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
Wessel J; Davis P
J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
[No Abstract] [Full Text] [Related]
24. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
Furst DE
Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
[TBL] [Abstract][Full Text] [Related]
25. Gold excretion and retention during auranofin treatment: a preliminary report.
Gottlieb NL
J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
[TBL] [Abstract][Full Text] [Related]
26. [Multicenter double-blind comparison of auranofin and Tauredon].
Kaik B; Bröll H
Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
[TBL] [Abstract][Full Text] [Related]
27. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
[TBL] [Abstract][Full Text] [Related]
28. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
Davis P; Landon M
J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
[No Abstract] [Full Text] [Related]
29. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
[No Abstract] [Full Text] [Related]
30. An analysis of worldwide safety experience with auranofin.
Heuer MA; Pietrusko RG; Morris RW; Scheffler BJ
J Rheumatol; 1985 Aug; 12(4):695-9. PubMed ID: 3932651
[TBL] [Abstract][Full Text] [Related]
31. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
32. Auranofin: experience to date.
Blodgett RC
Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
Rainer F; Ulreich A
Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
[No Abstract] [Full Text] [Related]
34. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
Harth M; Keown PA; Orange J
J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
[TBL] [Abstract][Full Text] [Related]
35. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
[TBL] [Abstract][Full Text] [Related]
36. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis.
Davies J; Bacon PA; Hall ND; Ring EF
Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670
[No Abstract] [Full Text] [Related]
37. Auranofin: a unique oral chrysotherapeutic agent.
Blodgett RC; Heuer MA; Pietrusko RG
Semin Arthritis Rheum; 1984 Feb; 13(3):255-73. PubMed ID: 6427927
[TBL] [Abstract][Full Text] [Related]
38. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
[TBL] [Abstract][Full Text] [Related]
39. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
Bröll H; Tausch G; Teherani DK
Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
[No Abstract] [Full Text] [Related]
40. Gold concentrations and toxicity during oral gold treatment with auranofin.
Sharma RP; Smillie J; Palmer DG
Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
